Insider Selling: Proto Labs, Inc. (PRLB) Director Sells 500 Shares of Stock

Proto Labs, Inc. (NYSE:PRLB) Director Rainer Gawlick sold 500 shares of Proto Labs stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $102.75, for a total value of $51,375.00. Following the completion of the sale, the director now directly owns 10,925 shares in the company, valued at $1,122,543.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Rainer Gawlick also recently made the following trade(s):

  • On Tuesday, November 21st, Rainer Gawlick sold 1,500 shares of Proto Labs stock. The stock was sold at an average price of $90.31, for a total value of $135,465.00.

Shares of Proto Labs, Inc. (NYSE:PRLB) traded up $1.10 during mid-day trading on Thursday, hitting $105.35. The stock had a trading volume of 102,788 shares, compared to its average volume of 123,667. The firm has a market capitalization of $2,767.17, a P/E ratio of 60.20, a PEG ratio of 2.26 and a beta of 1.07. Proto Labs, Inc. has a 1-year low of $48.00 and a 1-year high of $109.10.

Proto Labs (NYSE:PRLB) last issued its quarterly earnings results on Thursday, October 26th. The industrial products company reported $0.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.04. The business had revenue of $88.10 million for the quarter, compared to the consensus estimate of $85.68 million. Proto Labs had a return on equity of 11.63% and a net margin of 14.53%. The business’s quarterly revenue was up 12.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.51 earnings per share. equities research analysts forecast that Proto Labs, Inc. will post 1.89 earnings per share for the current year.

Several hedge funds have recently modified their holdings of PRLB. Russell Investments Group Ltd. increased its position in shares of Proto Labs by 25.3% in the 2nd quarter. Russell Investments Group Ltd. now owns 16,501 shares of the industrial products company’s stock valued at $1,110,000 after acquiring an additional 3,337 shares during the period. Schwab Charles Investment Management Inc. boosted its holdings in Proto Labs by 0.9% in the second quarter. Schwab Charles Investment Management Inc. now owns 105,104 shares of the industrial products company’s stock valued at $7,069,000 after purchasing an additional 973 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Proto Labs by 44.2% in the second quarter. Bank of New York Mellon Corp now owns 498,198 shares of the industrial products company’s stock valued at $33,504,000 after purchasing an additional 152,637 shares during the last quarter. Legal & General Group Plc boosted its holdings in Proto Labs by 11.2% in the second quarter. Legal & General Group Plc now owns 47,003 shares of the industrial products company’s stock valued at $3,161,000 after purchasing an additional 4,744 shares during the last quarter. Finally, BNP Paribas Arbitrage SA boosted its stake in shares of Proto Labs by 53.3% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 7,746 shares of the industrial products company’s stock worth $521,000 after acquiring an additional 2,693 shares in the last quarter.

Several research analysts recently commented on the company. Zacks Investment Research upgraded Proto Labs from a “hold” rating to a “buy” rating and set a $115.00 price target for the company in a research report on Thursday. Piper Jaffray Companies restated a “hold” rating and set a $84.00 target price on shares of Proto Labs in a research report on Thursday, December 14th. Craig Hallum set a $92.00 target price on Proto Labs and gave the company a “hold” rating in a research report on Monday, November 27th. Finally, BidaskClub lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Friday, October 6th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Proto Labs has an average rating of “Hold” and a consensus target price of $84.00.

ILLEGAL ACTIVITY WARNING: “Insider Selling: Proto Labs, Inc. (PRLB) Director Sells 500 Shares of Stock” was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2018/01/04/insider-selling-proto-labs-inc-prlb-director-sells-500-shares-of-stock.html.

Proto Labs Company Profile

Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.

Insider Buying and Selling by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply